Establishment and application of artificial intelligence voice follow-up system for differentiated thyroid cancer
Objective To establish an artificial intelligence voice follow-up system for differenti-ated thyroid cancer and evaluate the completeness and accuracy of information collection by this sys-tem.Methods Based on the postoperative medication and follow-up status of patients with differenti-ated thyroid cancer,an artificial intelligence voice follow-up system for differentiated thyroid cancer was established.From February 25 to 29,2024,a total of 2,471 differentiated thyroid cancer pa-tients without follow-up in the thyroid cancer database management system of the Department of Thy-roid and Breast Vascular Surgery of the Hospital were followed up by telephone,and 220 patients(approximately 10%of the total)were randomly selected for completeness and accuracy analyses of their call records.Results This study successfully established an artificial intelligence voice follow-up system for differentiated thyroid cancer,and the overall call connection rate was 88.9%.For pa-tients with successful calls,the average follow-up time of the artificial intelligence voice follow-up sys-tem was(1.7±0.5)minutes,the overall information collection completeness rate was 83.8%,with a completeness rate of 92.9%for follow-up at 3 months after surgery and 82.7%for long-term follow-up,and the differences were statistically significant(x2=15.200,P<0.001).The accuracy rate of information collection by this follow-up system was 94.1%.The accuracy rates of information collec-tion for patients who spoke dialect and Mandarin during follow-up were 92.2%and 95.4%respective-ly,and the difference was not statistically significant(x2=0.957,P=0.389).Conclusion The arti-ficial intelligence voice follow-up system for differentiated thyroid cancer has high efficiency,complete-ness,and accuracy in information collection,which can reduce human costs for follow-up and has good application prospects in large-scale follow-up of populations with differentiated thyroid cancer.